Atacama was founded by a team of experienced life science professionals to advance a treatment for hyperhidrosis and establishing proof-of-concept for TC-5214 in this indication. Hyperhidrosis represents a disease with a significant unmet medical and quality of life need where only a few treatments have been approved by regulatory authorities. Atacama expects to rapidly advance its program from proof of concept to a dose ranging study and anticipates initiating registration trials within two years. The Atacama team seek to develop a portfolio of dermatology focused products for worldwide markets. The team has identified opportunities for novel therapies for psoriasis and scleroderma and expects it may be able to advance these therapies from pre-clinical to clinical development next year.
View Top Employees from Atacama Therapeutics, Inc.Website | http://www.atacamatherapeutics.com |
Revenue | $1 million |
Employees | 1 (0 on RocketReach) |
Address | 65 William St Ste 200, Wellesley, Massachusetts 02481, US |
Phone | (781) 591-8927 |
Technologies |
HTML,
Google Analytics,
Bootstrap
+2 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Business Services |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 541714 Companies |
Looking for a particular Atacama Therapeutics, Inc. employee's phone or email?
The Atacama Therapeutics, Inc. annual revenue was $1 million in 2024.
Atacama Therapeutics, Inc. is based in Wellesley, Massachusetts.
The NAICS codes for Atacama Therapeutics, Inc. are [5417, 54, 541, 54171, 541714].
The SIC codes for Atacama Therapeutics, Inc. are [87, 873].